Track 1: Cancer Chemotherapy: 

Chemotherapy is drug therapy for cancer. Chemotherapy is use to killing the cancer cells, stopping cells from spreading, or decelerates their growth. But, it can also damage healthy cells, which causes side effects.

Track 2:  Cancer & Therapeutics: 

Cancer Therapeutics is to tackle the challenge of tumor heterogeneity, cancer evolution and resistance to drug treatments which include an ever-increasing array of tools at the disposal of clinicians in their treatment of this disease. It has endured a paradigm shift away from the traditional cytotoxic drugs towards the targeting of proteins intimately involved in driving the cancer phenotype. Cancer therapeutics has pursued the discovery and development of HSP90 inhibitors, as one way of preventing or overcoming drug resistance. All Anticancer agents act by depressing cell multiplication or normal functioning, DNA synthesis and by blocking or changing RNA and protein metabolite.

Track 3: Cancer Cell Biology and Cancer Biomarker:

 Cancer cells are cells that divide relentlessly, forming solid tumors or flooding the blood with abnormal cells. Cell biology encompasses both prokaryotic and eukaryotic cells and can be divided into many sub-topics which may include the study of cell metabolism, cell communication, cell cycle, biochemistry, and cell composition. Cells are the basic and smallest units of life that make up the human body. The study of cells is called cell biology. Certain cells may create a mass called a tumor. Cancer Biomarkers or the molecular markers are the biological molecules such as DNA, RNA, and Proteins, genes or the processes such as apoptosis and proliferation by which a specific disease, condition or any abnormalities in the body can be identified. It is a measurable indicator in a biological system and can be found in blood, tissues, specific organs, cell lines and in other body fluids.

Track 4: Radiation Therapy:

Radiation Therapy is a type of cancer treatment that is used to treat the cancer patients. In radiation therapy oncologist uses beams of intense energy to kill cancer cells. Radiation therapy commonly uses X-rays, but protons or other types of energy also can be used. "Radiation therapy" commonly refers to external beam radiation therapy

Track 5: Cancer Therapy & Treatments:

Cancer Therapy expresses the treatment of cancer in a patient, generally with surgery, chemotherapy and/or radiotherapy. Oncologist also used targeted therapies for some cancer types. Oncologist also used many different types of therapy, with the aim of relieving the indication of cancer, such as pain.

Track 6: Cancer Vaccines:

Some types of cancer are caused by viruses (oncoviruses). Conventional vaccines opposed to those viruses, such as HPV vaccine and hepatitis B vaccine, stop those types of cancer.

Track 7: Cancer Nanotechnology:

Cancer nanotechnology is a bough of nanotechnology bothered with the approach of both nanomaterials (such as nanoparticles for tumor imaging or drug delivery) and nanotechnology approaches (such as nanoparticle-based theranostics) to the identification and treatment of cancer.

Track 8: Breast Cancer:

Breast cancer is an infection in which cells in the breast get larger out of control. Breast cancer can begin in different section of the breast. A breast has three main parts

•          Lobules

•          Ducts

•          Connective tissue

Track 9: Organ-Defined Cancers:

In Organ Specified Cancers we found the cancer in the different body organ. Its occurrence is showing a growing shift in various parts of the body and has been a remarkable public health problem without being affected by move forward in the understanding of the molecular and cellular events that prime.

Track 10: Lung cancer:

Lung cancer is the unconstrained extension of uncommon cells in one or both lungs. These uncommon cells do not carry out the role of normal lung cells and do not develop into fit lung cells.

Track 11: Cancer drugs:

Discover about individual cancer drugs, cancer drug combinations, possible side effects and how to survive with them.

Track 12: Hormone Therapy:

Hormone therapy chunks or takedown the number of hormones in the body to stop or slow down the swelling of cancer.

What is Cancer: Cancer occurs when cells split in an uncontrolled way. Observe about different types and how they begin and spread.

Stem cell and bone marrow transplants: Bone marrow or stem cell transplant are dealings with some types of cancer. You have them with high dose chemotherapy and sometimes radiotherapy.

Track 13: Cancer Diagnosis:

If you have a sign or a screening test result that recommend cancer, doctor must find out it is really due to cancer or some other beginning. The doctor may ask about your medical history and do a physical exam. To tell for sure that you have cancer or not you need to do order lab tests, imaging tests (scans), or other tests or procedures. You may also need a biopsy to know it is cancer or not.

Track 14: Personalized Medicine:

Personalized Medicine requires using detail about a person’s cancer to help diagnose, treat and detect about how effectively treatment is working.

Total Body Irradiation (TBI): When Oncologist use Radiotherapy to the whole body is called total body irradiation or TBI.
Genes and Inherited Lancer: Inherited gene changes can enlarge the possibility of some types of cancer. Observe about gene changes and genetic testing.
Causes of Cancer: Discover about the possible causes of cancer and about how you can lessen your possibility of developing it.

Track 15: Skin Cancer (Melanoma): 

Melanoma take place when the pigment producing cells give color to the skin become cancerous. Sign might cover a new, uncommon growth or a change in an existing mole. Melanomas can take place anywhere on the body.

Track 16: Brain Tumors:

A brain tumor is a mass or growth of unusual cells in your brain. Many dissimilar types of brain tumors are there. Brain tumors can start in your brain or cancer can start in other parts of your body and extend to your brain.

Track 17: Surgery:

Surgery is one of the leading treatments for many types of cancer. Discover about when and why you might have it and what look forward to and following your operation.

Track 18: Lung Cancer Surgery: 

Lung cancer surgery can involve removing a portion of the lung or the entire lung. An operation to remove the lung cancer and a small portion of healthy tissue is called a wedge resection. Removing a larger area of the lung is called segmental resection. Surgery to remove one of the lung's five lobes is called lobectomy. Removing an entire lung is called pneumonectomy.

Track 19: ERAS:

Enhanced Recovery After Surgery (ERAS) refers to patient-centered, evidence-based, multidisciplinary team developed pathways for a surgical specialty and facility culture to reduce the patient’s surgical stress response, optimize their physiologic function, and facilitate recovery. These care pathways form an integrated continuum, as the patient moves from home through the pre-hospital / preadmission, preoperative, intraoperative, and postoperative phases of surgery and home again.

Conference Series LLC Ltd successfully anchored its major "2^nd International Conference on Clinical Oncology & Radiation Therapy" Webinar scheduled for October 07-08, 2021

Global Cancer 2021 is distinguished by the presence of members of the editorial board of journals, scientists, young researchers, trade commissioners, and student communities supported representing more than 25 countries that have made this conference rewarding and fruitful.

Our 2nd International Conference on Clinical Oncology & Radiation Therapy was based on the theme “Latest Innovation in Cancer Treatment and Oncology research” which has encrusted the below scientific sessions:

Radiation Oncology

Cancer & Stem Cell Therapy

Surgical Oncology

Cancer Immunotherapy

Cancer Cell Biology and Genetics

Precision Cancer Medicine & Oncology

Organ-Defined Cancers

Cancer Pharmacology 

Cancer Awareness and Survival

The conference received address & great support was extended by the keynote lectures mentioned below:

Thomas W Kozlowski, Principal Consultant, JCI, Singapore

Vinay Sharma, University of the Witwatersrand-Johannesburg, South Africa

Joshua K S Ko, Hong Kong Baptist University, China

Salam Azad, Soheli Mirza Cancer Foundation

Kunal Sharma, SRL Diagnostics, India

Conference Series LLC Ltd wishes to acknowledge with its deep sincere gratitude to all the supporters from the Editorial Board Members of our Open Access Journals, Keynote speakers, Valuable speakers, students, delegates for their contribution to make this event a huge success.

We thank you once again for the huge exquisite response. This inspires us to continue organizing events and conferences to advance oncology research. Conference Series LLC Ltd is pleased to announce Oncology and Radiology 2022 which is going to held on October 27-28, 2022 in Amsterdam, Netherlands.

The global cancer / tumor profiling market valued at $13.30 billion in 2012. By the end of 2013, the market was estimated at $14.99 billion and is expected to reach about $35 billion in 2018, with compound annual growth rate of 18.50%. 2018. Global spending on oncology reached $91 billion in 2013 and grew by 5% annually, reaching $100 billion in 2015. Key players in the cancer and tumor market are Boreal Genomics Inc. (United States), Caris Life Sciences. (United States), Genomic Health Inc. (United States), Illumina Inc. (United States), Life Technologies Corporation (United States), NeoGenomics Laboratories (United States), Oxford Gene Technology Ltd. (United Kingdom), Precision Therapeutics Inc. (United States), bioTheranostics (United States), Proteome Sciences PLC (United Kingdom), Agendia (Netherlands), Nanostring Technologies (United States), Rational Therapeutics (United States), United States), Oncopath Laboratories (United States) and RiboMedBiotechnologies Inc. (WE.). The global cancer diagnostic market is expected to reach $13.1 billion in 2020, up from about $7.1 billion in 2015, with a CAGR of 12.9%.

The market is dominated by North America, followed by Europe, Asia and the rest of the world. The Asian cancer diagnostic market is expected to grow at its fastest pace from 2015 to 2020. According to the market, the global market for oncology drugs is expected to reach $111.9 billion by 2020. The patent expires in Key anti-cancer drugs such as Herceptin, Erbitux, Rituxan and Avastin are expected to drive growth in the cancer biosimilar market by 2021.